webleads-tracker

US Sunshine Act

Open Payments Data 2017: Significant Drop in Number of Payments

Pharma Compliance Info Open Payments Data 2017: Significant Drop in Number of Payments US Sunshine Act

On Friday, June 29, 2018 the Centers for Medicare & Medicaid Services (“CMS”) released the 2017 Open Payments Data, which covers transactions data collected from January 1, 2016 through December 31, 2016. The total dollar amount of payments totaled $8.4 billion (General Payments: $2.82 billion; Research Payments: $4.66 billion; the total records published totaled 11.54 million. The 2017 Open Payments Data shows a 4.7% drop in the total amount of payments from applicable manufacturers and group purchasing organizations (“GPO”) and a 6.9% drop in the total number of payments. To read the article by Thomas Sullivan

Read More »

The Patient Advocacy Groups that Accept the Most Big Pharma Money

Pharma Compliance Info The Patient Advocacy Groups that Accept the Most Big Pharma Money US Sunshine Act

Eight out of ten patient advocacy groups accept money from drug and medical device companies. Pharmaceutical donations make up more than half of the yearly income of some patient advocacy groups. Are these good natured corporate donations, or just another way that Big Pharma exerts their influence beyond corporate walls? That question isn’t an easy one to answer. But the first step in understanding how large of a role pharmaceutical companies play in organizations like the American Diabetes Association or the American Heart Association is to follow the money. Pharmaceutical donations make up more than half of the yearly income …

Read More »

Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018

Pharma Compliance Info Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018 US Sunshine Act

As a follow-up to Senator Claire McCaskill’s long running opioid investigation and report titled: Fueling an Epidemic: Exposing the Financial Ties Between Opioid Manufacturers and Third Party Advocacy Groups, the senator released the Patient Advocacy Transparency Act of 2018.  The proposed legislation, if adopted, would expand Open Payment reporting to include television programs, websites, and payments to patient advocacy organizations, professional societies, clinical trial organizations, and Continuing Medica Education (CME) providers. This legislation amends the Physician Payment Sunshine Act to: Broaden the reporting definition of “grants” to include various types of educational grants and “capacity building grants”; Also expands reporting for: fundraising …

Read More »

Bipartisan Trio of Senators Introduces New Open Payments Transparency Bill

Pharma Compliance Info Bipartisan Trio of Senators Introduces New Open Payments Transparency Bill US Sunshine Act

Senator Chuck Grassley, along with Senator Sherrod Brown and Senator Richard Blumenthal recently introduced bipartisan legislation that is expected to increase transparency in the prescription drug payment process, S. 2891, The “Fighting the Opioid Epidemic with Sunshine Act.” The Fighting the Opioid Epidemic with Sunshine Act will require drug companies and medical device makers to publicly disclose the same payments made to nurse practitioners and physician assistants for promotional talks, consulting, and other interactions. Nurse practitioners and physician assistants write a significant number of prescriptions and should be included in these disclosures. The Senators believe that “by shining a light on the …

Read More »

Comparing Transparency Reporting Requirements in Canada, the United States and Europe

Pharma Compliance Info Comparing Transparency Reporting Requirements in Canada, the United States and Europe US Sunshine Act

The Strengthening Quality and Accountability for Patients Act 2017 (the “Transparency Act”) was passed in December 2017 and requires the reporting of transfers of value (“TOV”) from manufacturers (e.g., pharmaceutical, medical device, generics, medicinal marijuana, etc.), pharmacies, laboratories, organizers of continuing education events and “a prescribed person or entity” to prescribed recipients in Ontario. Like the U.S. Sunshine Act and the EFPIA reporting requirements, the Transparency Act was created with the goal of strengthening transparency by requiring companies to track and report certain payments and items of value. However, the reporting requirements under the Act are still somewhat unclear and …

Read More »
X